Kristine Freyaldenhoven, MD
General Surgery · Overland Park, KSNPI 1801892815
Payments from drug & device makers
Across 49 payments — averaging $24.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$253
- Takeda Pharmaceuticals U.S.A., Inc.$134
- Elucent Medical$121
- TELA Bio, Inc.$89
- Dilon Technologies, Inc.$73
- Mimedx Group, Inc.$69
- plus $466 from 21 others
What the payments were for
- Food & beverage$1,205100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 10 | $253 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $134 |
| Elucent Medical | 1 | $121 |
| TELA Bio, Inc. | 3 | $89 |
| Dilon Technologies, Inc. | 3 | $73 |
| Mimedx Group, Inc. | 3 | $69 |
| Medtronic | 2 | $55 |
| AbbVie | 2 | $43 |
| Solventum Corporation | 2 | $36 |
| Avita Medical Americas, LLC | 1 | $35 |
| Sirius Medical Systems | 1 | $26 |
| Davol Inc. | 1 | $23 |
| Heron Therapeutics, Inc. | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Stryker | 1 | $22 |
| Melinta Therapeutics, LLC | 1 | $21 |
| Kerecis Limited | 1 | $21 |
| Innocoll Pharmaceuticals Limited | 1 | $17 |
| Baudax Bio Inc. | 1 | $17 |
| KUB Technologies Inc. | 1 | $14 |
| Osiris Therapeutics Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Cardinal Health 414 LLC | 1 | $14 |
| Focal Therapeutics, Inc. | 1 | $12 |
| Leica Microsystems Inc. | 1 | $12 |
| Myriad Genetic Laboratories, Inc. | 1 | $11 |
How this compares
Too few general surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 13 | $293 |
| Mupirocin | 17 | $134 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $95 |
| Cephalexin | 20 | $93 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Overland Park
- Clay KingKansas City$5K
- Todd BrownWichita$361
- Todd MurphyWichita$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.